99 related articles for article (PubMed ID: 2513868)
1. The effect of phospholipase C on plasma factor VII.
Hubbard AR; Parr LJ
Br J Haematol; 1989 Nov; 73(3):360-4. PubMed ID: 2513868
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase C mediated inhibition of factor VII requires triglyceride-rich lipoproteins.
Hubbard AR; Parr LJ
Thromb Res; 1991 May; 62(4):335-44. PubMed ID: 1866715
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis.
Mukherjee M; Dawson G; Sembhi K; Kakkar VV
Thromb Haemost; 1996 Oct; 76(4):500-1. PubMed ID: 8902984
[TBL] [Abstract][Full Text] [Related]
4. FVII dependent coagulation activation in citrated plasma by polymer hydrogels.
Casey BJ; Behrens AM; Hess JR; Wu ZJ; Griffith BP; Kofinas P
Biomacromolecules; 2010 Dec; 11(12):3248-55. PubMed ID: 21058718
[TBL] [Abstract][Full Text] [Related]
5. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
[TBL] [Abstract][Full Text] [Related]
6. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
7. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Kario K; Miyata T; Sakata T; Matsuo T; Kato H
Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
Morrissey JH; Macik BG; Neuenschwander PF; Comp PC
Blood; 1993 Feb; 81(3):734-44. PubMed ID: 8427965
[TBL] [Abstract][Full Text] [Related]
9. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy.
Bladbjerg EM; Larsen LF; Ostergaard P; Jespersen J
Blood Coagul Fibrinolysis; 2000 Dec; 11(8):739-45. PubMed ID: 11132652
[TBL] [Abstract][Full Text] [Related]
11. Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart".
Mariani G; Bernardi F; Bertina R; Vicente VV; Prydz H; Samama M; Sandset PM; Di Nucci GD; Testa MG; Bendz B; Chiarotti F; Ciarla MV; Strom R
Haematologica; 1999 Jul; 84(7):620-6. PubMed ID: 10406904
[TBL] [Abstract][Full Text] [Related]
12. Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
Girolami A; Bertozzi I; de Marinis GB; Bonamigo E; Fabris F
Hematology; 2011 Sep; 16(5):308-12. PubMed ID: 21902896
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven).
Johannessen M; Nielsen G; Nordfang O
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S159-64. PubMed ID: 10850583
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
Carvalho de Sousa J; Bruckert E; Soria C; Caen JP
Nouv Rev Fr Hematol (1978); 1989; 31(1):13-5. PubMed ID: 2915918
[TBL] [Abstract][Full Text] [Related]
16. A high-fat meal does not activate blood coagulation factor VII in minipigs.
Olsen AK; Larsen LF; Bladbjerg EM; Hansen AK; Jespersen J; Marckmann P
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):117-22. PubMed ID: 11302473
[TBL] [Abstract][Full Text] [Related]
17. Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men.
Tholstrup T; Miller GJ; Bysted A; Sandström B
Am J Clin Nutr; 2003 May; 77(5):1125-32. PubMed ID: 12716662
[TBL] [Abstract][Full Text] [Related]
18. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
[TBL] [Abstract][Full Text] [Related]
19. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Chapman J; Truffert J; Dairou F; De Gennes JL; Caen JP
Haemostasis; 1989; 19(3):125-30. PubMed ID: 2744628
[TBL] [Abstract][Full Text] [Related]
20. Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects.
Sanders TA; Oakley FR; Cooper JA; Miller GJ
Am J Clin Nutr; 2001 Apr; 73(4):715-21. PubMed ID: 11273845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
